Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients With Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy
Cancer immunology research - United States
doi 10.1158/2326-6066.cir-15-0302
Full Text
Open PDFAbstract
Available in full text
Date
May 13, 2016
Authors
Publisher
American Association for Cancer Research (AACR)